First, which preparation?
A page headed NAD+ may be discussing a supplement or an injectable preparation. The first task is to establish which one. A general ingredient name leaves out the form, how it is intended to be used and the rules that apply.
NAD+ is not an FDA-approved drug. Injectable NAD+ is commonly compounded. Compounded NAD+ is not FDA-approved. A prescription does not change that approval status.
Approval and quality are real questions.
An injectable NAD+ preparation has been recalled for contamination. That warning concerns an identified product problem; it does not show that every preparation had the same problem.
It also does not tell us what another preparation will do for a person. Product quality, evidence of benefit and the suitability of treatment are separate questions. A reassuring answer to one cannot answer all three.
A route to review, with limits.
Promise offers NAD+ consultations through licensed U.S. providers. A provider reviews each request and decides whether a prescription is appropriate. Not everyone qualifies. Licensed U.S. compounding pharmacies have their own responsibilities and decide separately whether a prescription can be prepared lawfully.
A research-only sale is a different transaction. Material labeled “not for human use” does not come with a review of your health. A certificate about a sample is not a personal care decision.
Let the questions get specific.
- What exact ingredient and form are we discussing?
- What evidence concerns that preparation, rather than a different product?
- What quality checks and follow-up would be part of care?
- What remains uncertain about the risks?
Summer does not turn a wellness term into a treatment recommendation. The word on the page is a starting point for understanding, rather than a reason to use a product. Our common questions explain the roles of the provider and pharmacy. The glossary gives unfamiliar words a little more room.